Royal Philips has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its AlluraClarity live image guidance system in the United States.
The system is equipped with Philips’ ClarityIQ technology in order to provide high quality imaging using lower X-ray dose levels. Because some imaging guided procedures can be lengthy and complex, keeping radiation doses low is a an advantage stated Dr. Marco van Strijen, an interventional radiologist at the St. Antonius Hospital Utrecht/Nieuwegein, the Netherlands, in the Philips press release. The hospital has been using the system for more than a year as it was approved in most international markets, including Europe, first.
ClarityIQ technology will also be available as an upgrade for the majority of Philips’ installed base of monoplane and biplane interventional X-ray systems, the company noted in the press release.